Sharon Benzeno

2.0k citations
13 papers · 693 indexed · h-index 8
Topics
Cancer Immunotherapy and Biomarkers (3 papers)Viral Infectious Diseases and Gene Expression in Insects (2 papers)Immunotherapy and Immune Responses (2 papers)

In The Last Decade

Sharon Benzeno

11 papers receiving 674 citations

Peers

Sharon Benzeno
Comparison fields: 5 of 79
  • Molecular Biology 512
  • Oncology 151
  • Genetics 129
  • Pharmaceutical Science 75
  • Cancer Research 64
Replace Xiaomin Ni with:
Xiaomin Ni Germany
Nerea Gallastegui Germany
Nobuhiro Oikawa Japan
James R. Hitchin United Kingdom
Anne Marinier Canada
Ashok R. Bapat United States
E. A. Partridge United Kingdom
Eva‐Laure Matera France
Sophie Roerink Netherlands
Czesław Radzikowski Poland
Sharon Benzeno relative to Xiaomin Ni Germany Xiaomin Ni's profile →
Citations per field
00.5×11.5×
Xiaomin Ni · 1×
Citations per year

Countries citing papers authored by Sharon Benzeno

Since Specialization
Citations

This map shows the geographic impact of Sharon Benzeno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Benzeno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Benzeno more than expected).

Fields of papers citing papers by Sharon Benzeno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Benzeno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Benzeno. The network helps show where Sharon Benzeno may publish in the future.

Co-authorship network of co-authors of Sharon Benzeno

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Benzeno. A scholar is included among the top collaborators of Sharon Benzeno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Benzeno. Sharon Benzeno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 2
5 22
6 110
7 6
8 143
9 33
10 125
11 45
12 113
13 92

About Sharon Benzeno

Sharon Benzeno is a scholar working on Aging, Physiology and Oncology, having authored 13 papers that have together received 693 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Pharmaceutical Science (75 citations), Molecular Biology (512 citations) and Oncology (151 citations). Sharon Benzeno has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include J. Alan Diehl, Jie Rao, Avrom J. Caplan, Simon Benita, Albert Fliss, Helen L. Reeves, Goutham Narla, Amanda Katz, Noam Harpaz and Eldad A. Hod. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026